CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.24

EPS Forecast

$6.1

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
REPLReplimune Group IncDNLIDenali Therapeutics IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncNVAXNovavax IncRGENRepligen CorpTECHBio-techne CorpMRNAModerna Inc